3.8.0.1 html 119 204 1 false 52 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.progenics.com/20180331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.progenics.com/20180331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.progenics.com/20180331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.progenics.com/20180331/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://www.progenics.com/20180331/role/statement-condensed-consolidated-statements-of-comprehensive-loss-unaudited Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statement of Stockholders' Equity (Unaudited) Sheet http://www.progenics.com/20180331/role/statement-condensed-consolidated-statement-of-stockholders-equity-unaudited Condensed Consolidated Statement of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.progenics.com/20180331/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Summary of Significant Accounting Policies Sheet http://www.progenics.com/20180331/role/statement-note-1-summary-of-significant-accounting-policies- Note 1 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 2 - New Accounting Pronouncements Sheet http://www.progenics.com/20180331/role/statement-note-2-new-accounting-pronouncements Note 2 - New Accounting Pronouncements Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Net Loss Per Share Sheet http://www.progenics.com/20180331/role/statement-note-3-net-loss-per-share Note 3 - Net Loss Per Share Notes 10 false false R11.htm 010 - Disclosure - Note 4 - Fair Value Measurements Sheet http://www.progenics.com/20180331/role/statement-note-4-fair-value-measurements Note 4 - Fair Value Measurements Notes 11 false false R12.htm 011 - Disclosure - Note 5 - Accounts Receivable Sheet http://www.progenics.com/20180331/role/statement-note-5-accounts-receivable Note 5 - Accounts Receivable Notes 12 false false R13.htm 012 - Disclosure - Note 6 - Goodwill, In-process Research and Development, and Other Intangible Assets Sheet http://www.progenics.com/20180331/role/statement-note-6-goodwill-inprocess-research-and-development-and-other-intangible-assets Note 6 - Goodwill, In-process Research and Development, and Other Intangible Assets Notes 13 false false R14.htm 013 - Disclosure - Note 7 - Accrued Expenses Sheet http://www.progenics.com/20180331/role/statement-note-7-accrued-expenses Note 7 - Accrued Expenses Notes 14 false false R15.htm 014 - Document - Note 8 - Commitments and Contingencies Sheet http://www.progenics.com/20180331/role/statement-note-8-commitments-and-contingencies Note 8 - Commitments and Contingencies Uncategorized 15 false false R16.htm 015 - Disclosure - Note 9 - Non-recourse Long-term Debt, Net Sheet http://www.progenics.com/20180331/role/statement-note-9-nonrecourse-longterm-debt-net Note 9 - Non-recourse Long-term Debt, Net Uncategorized 16 false false R17.htm 016 - Disclosure - Note 10 - Stockholders' Equity Sheet http://www.progenics.com/20180331/role/statement-note-10-stockholders-equity Note 10 - Stockholders' Equity Uncategorized 17 false false R18.htm 017 - Disclosure - Note 11 - Stock-based Compensation Sheet http://www.progenics.com/20180331/role/statement-note-11-stockbased-compensation Note 11 - Stock-based Compensation Uncategorized 18 false false R19.htm 018 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.progenics.com/20180331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 19 false false R20.htm 019 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Tables) Sheet http://www.progenics.com/20180331/role/statement-note-1-summary-of-significant-accounting-policies-tables Note 1 - Summary of Significant Accounting Policies (Tables) Uncategorized 20 false false R21.htm 020 - Disclosure - Note 3 - Net Loss Per Share (Tables) Sheet http://www.progenics.com/20180331/role/statement-note-3-net-loss-per-share-tables Note 3 - Net Loss Per Share (Tables) Uncategorized 21 false false R22.htm 021 - Disclosure - Note 4 - Fair Value Measurements (Tables) Sheet http://www.progenics.com/20180331/role/statement-note-4-fair-value-measurements-tables Note 4 - Fair Value Measurements (Tables) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 5 - Accounts Receivable (Tables) Sheet http://www.progenics.com/20180331/role/statement-note-5-accounts-receivable-tables Note 5 - Accounts Receivable (Tables) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 6 - Goodwill, In-process Research and Development, and Other Intangible Assets (Tables) Sheet http://www.progenics.com/20180331/role/statement-note-6-goodwill-inprocess-research-and-development-and-other-intangible-assets-tables Note 6 - Goodwill, In-process Research and Development, and Other Intangible Assets (Tables) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 7 - Accrued Expenses (Tables) Sheet http://www.progenics.com/20180331/role/statement-note-7-accrued-expenses-tables Note 7 - Accrued Expenses (Tables) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 9 - Non-recourse Long-term Debt, Net (Tables) Sheet http://www.progenics.com/20180331/role/statement-note-9-nonrecourse-longterm-debt-net-tables Note 9 - Non-recourse Long-term Debt, Net (Tables) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 10 - Stockholders' Equity (Tables) Sheet http://www.progenics.com/20180331/role/statement-note-10-stockholders-equity-tables Note 10 - Stockholders' Equity (Tables) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 11 - Stock-based Compensation (Tables) Sheet http://www.progenics.com/20180331/role/statement-note-11-stockbased-compensation-tables Note 11 - Stock-based Compensation (Tables) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.progenics.com/20180331/role/statement-note-1-summary-of-significant-accounting-policies-details-textual Note 1 - Summary of Significant Accounting Policies (Details Textual) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) Sheet http://www.progenics.com/20180331/role/statement-note-1-summary-of-significant-accounting-policies-disaggregation-of-revenue-details Note 1 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://www.progenics.com/20180331/role/statement-note-1-summary-of-significant-accounting-policies-property-and-equipment-details Note 1 - Summary of Significant Accounting Policies - Property and Equipment (Details) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 3 - Net Loss Per Share - Calculations of Net Loss Per Share, Basic and Diluted (Details) Sheet http://www.progenics.com/20180331/role/statement-note-3-net-loss-per-share-calculations-of-net-loss-per-share-basic-and-diluted-details Note 3 - Net Loss Per Share - Calculations of Net Loss Per Share, Basic and Diluted (Details) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 3 - Net Loss Per Share - Common Shares Excluded From Calculation of Diluted Net Loss Per Share (Details) Sheet http://www.progenics.com/20180331/role/statement-note-3-net-loss-per-share-common-shares-excluded-from-calculation-of-diluted-net-loss-per-share-details Note 3 - Net Loss Per Share - Common Shares Excluded From Calculation of Diluted Net Loss Per Share (Details) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 4 - Fair Value Measurements (Details Textual) Sheet http://www.progenics.com/20180331/role/statement-note-4-fair-value-measurements-details-textual Note 4 - Fair Value Measurements (Details Textual) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 4 - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://www.progenics.com/20180331/role/statement-note-4-fair-value-measurements-assets-and-liabilities-measured-at-fair-value-on-recurring-basis-details Note 4 - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 4 - Fair Value Measurements - Contingent Consideration Liabilities (Details) Sheet http://www.progenics.com/20180331/role/statement-note-4-fair-value-measurements-contingent-consideration-liabilities-details Note 4 - Fair Value Measurements - Contingent Consideration Liabilities (Details) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 4 - Fair Value Measurements - Quantitative Information for Fair Value Measurement of Level 3 (Details) Sheet http://www.progenics.com/20180331/role/statement-note-4-fair-value-measurements-quantitative-information-for-fair-value-measurement-of-level-3-details Note 4 - Fair Value Measurements - Quantitative Information for Fair Value Measurement of Level 3 (Details) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 4 - Fair Value Measurements - Summary of Activities in Financial Instruments With Level 3 Inputs (Details) Sheet http://www.progenics.com/20180331/role/statement-note-4-fair-value-measurements-summary-of-activities-in-financial-instruments-with-level-3-inputs-details Note 4 - Fair Value Measurements - Summary of Activities in Financial Instruments With Level 3 Inputs (Details) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) Sheet http://www.progenics.com/20180331/role/statement-note-5-accounts-receivable-summary-of-accounts-receivable-details Note 5 - Accounts Receivable - Summary of Accounts Receivable (Details) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 6 - Goodwill, In-process Research and Development, and Other Intangible Assets (Details Textual) Sheet http://www.progenics.com/20180331/role/statement-note-6-goodwill-inprocess-research-and-development-and-other-intangible-assets-details-textual Note 6 - Goodwill, In-process Research and Development, and Other Intangible Assets (Details Textual) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 6 - Goodwill, In-process Research and Development, and Other Intangible Assets - Summary of Goodwill and Intangible Assets (Details) Sheet http://www.progenics.com/20180331/role/statement-note-6-goodwill-inprocess-research-and-development-and-other-intangible-assets-summary-of-goodwill-and-intangible-assets-details Note 6 - Goodwill, In-process Research and Development, and Other Intangible Assets - Summary of Goodwill and Intangible Assets (Details) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 7 - Accrued Expenses - Summary of Accrued Expenses (Details) Sheet http://www.progenics.com/20180331/role/statement-note-7-accrued-expenses-summary-of-accrued-expenses-details Note 7 - Accrued Expenses - Summary of Accrued Expenses (Details) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 9 - Non-recourse Long-term Debt, Net (Details Textual) Sheet http://www.progenics.com/20180331/role/statement-note-9-nonrecourse-longterm-debt-net-details-textual Note 9 - Non-recourse Long-term Debt, Net (Details Textual) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 9 - Non-recourse Long-term Debt, Net - Summary of Royalty-backed Loan (Details) Sheet http://www.progenics.com/20180331/role/statement-note-9-nonrecourse-longterm-debt-net-summary-of-royaltybacked-loan-details Note 9 - Non-recourse Long-term Debt, Net - Summary of Royalty-backed Loan (Details) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 10 - Stockholders' Equity (Details Textual) Sheet http://www.progenics.com/20180331/role/statement-note-10-stockholders-equity-details-textual Note 10 - Stockholders' Equity (Details Textual) Uncategorized 45 false false R46.htm 045 - Disclosure - Note 10 - Stockholders' Equity - Components of Accumulated Other Comprehensive Loss (Details) Sheet http://www.progenics.com/20180331/role/statement-note-10-stockholders-equity-components-of-accumulated-other-comprehensive-loss-details Note 10 - Stockholders' Equity - Components of Accumulated Other Comprehensive Loss (Details) Uncategorized 46 false false R47.htm 046 - Disclosure - Note 11 - Stock-based Compensation (Details Textual) Sheet http://www.progenics.com/20180331/role/statement-note-11-stockbased-compensation-details-textual Note 11 - Stock-based Compensation (Details Textual) Uncategorized 47 false false R48.htm 047 - Disclosure - Note 11 - Stock-based Compensation - Summary of Option Activity Under the Plans (Details) Sheet http://www.progenics.com/20180331/role/statement-note-11-stockbased-compensation-summary-of-option-activity-under-the-plans-details Note 11 - Stock-based Compensation - Summary of Option Activity Under the Plans (Details) Uncategorized 48 false false R49.htm 048 - Disclosure - Note 11 - Stock-based Compensation - Assumptions Used in Computing the Fair Value of Option Grants (Details) Sheet http://www.progenics.com/20180331/role/statement-note-11-stockbased-compensation-assumptions-used-in-computing-the-fair-value-of-option-grants-details Note 11 - Stock-based Compensation - Assumptions Used in Computing the Fair Value of Option Grants (Details) Uncategorized 49 false false R50.htm 049 - Disclosure - Note 11 - Stock-based Compensation - Allocation of Recognized Period Costs (Details) Sheet http://www.progenics.com/20180331/role/statement-note-11-stockbased-compensation-allocation-of-recognized-period-costs-details Note 11 - Stock-based Compensation - Allocation of Recognized Period Costs (Details) Uncategorized 50 false false All Reports Book All Reports pgnx-20180331.xml pgnx-20180331.xsd pgnx-20180331_cal.xml pgnx-20180331_def.xml pgnx-20180331_lab.xml pgnx-20180331_pre.xml http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true